Literature DB >> 8761374

RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material.

G H Williams1, S Rooney, G A Thomas, G Cummins, E D Williams.   

Abstract

Activation of the RET tyrosine kinase domain occurs in a proportion of thyroid papillary carcinomas. Three chromosomal rearrangements have been described, of which PTC1 is the commonest. Wide differences (2.5-25%) in frequency of PTC1 in different populations have been reported; it is not clear whether these are due to environmental factors, racial differences or technical reasons. We have developed a simple and rapid reverse transcriptase nested polymerase chain reaction (RT-nPCR) method enabling the detection of gene expression from single 5 microns sections of formalin-fixed paraffin wax-embedded archival material. We have applied this approach to detect expression of the RET tyrosine kinase domain, allowing identification of RET activation resulting from any rearrangement, whether characterised or not, or from overexpression. A retrospective study was performed on 22 adult and 21 childhood papillary carcinomas. Thirteen of 22 (59%) adult and 10 of 21 (48%) childhood carcinomas showed evidence of RET activation, demonstrating a major role for the RET oncogene in UK thyroid papillary carcinogenesis. This study also shows a similar frequency of RET activation in both children and adults. The use of a technique that allows reliable amplification of RNA from archival material, using primers chosen in different exons so that amplified products are readily distinguished from genomic DNA, will allow correlation of translocations and chromosomal rearrangements with a variety of specific tumour types.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761374      PMCID: PMC2074679          DOI: 10.1038/bjc.1996.405

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  ret transforming gene encodes a fusion protein homologous to tyrosine kinases.

Authors:  M Takahashi; G M Cooper
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

2.  Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

Authors:  M Takahashi; Y Buma; T Iwamoto; Y Inaguma; H Ikeda; H Hiai
Journal:  Oncogene       Date:  1988-11       Impact factor: 9.867

3.  Carcinomas in childhood. A registry-based study of incidence and survival.

Authors:  W R McWhirter; C A Stiller; E L Lennox
Journal:  Cancer       Date:  1989-06-01       Impact factor: 6.860

4.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Authors:  M Grieco; M Santoro; M T Berlingieri; R M Melillo; R Donghi; I Bongarzone; M A Pierotti; G Della Porta; A Fusco; G Vecchio
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

5.  Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident.

Authors:  T Ito; T Seyama; K S Iwamoto; T Mizuno; N D Tronko; I V Komissarenko; E D Cherstovoy; Y Satow; N Takeichi; K Dohi
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

6.  Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method.

Authors:  Y Ishizaka; S Kobayashi; T Ushijima; S Hirohashi; T Sugimura; M Nagao
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

7.  Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia.

Authors:  C R Bartram; A de Klein; A Hagemeijer; T van Agthoven; A Geurts van Kessel; D Bootsma; G Grosveld; M A Ferguson-Smith; T Davies; M Stone
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

8.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

Authors:  R Dalla-Favera; M Bregni; J Erikson; D Patterson; R C Gallo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Identification of tumour-specific translocations in archival material.

Authors:  G H Williams; E D Williams
Journal:  J Pathol       Date:  1995-03       Impact factor: 7.996

10.  Childhood thyroid cancer in England and Wales.

Authors:  H R Harach; E D Williams
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more
  6 in total

Review 1.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  High prevalence of RET tyrosine kinase activation in Mexican patients with papillary thyroid carcinomas.

Authors:  I Martínez; A Mantilla; M E Medrano; R Hernández; D M Hernández; M Lazos; H Santiago; B González; A Hidalgo; M Salcedo
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 3.  RET proto-oncogene mutations in thyroid carcinomas: clinical relevance.

Authors:  F Pacini; R Elisei; C Romei; A Pinchera
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

4.  Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.

Authors:  B Mayr; E Pötter; P Goretzki; J Rüschoff; W Dietmaier; C Hoang-Vu; H Dralle; G Brabant
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Gene rearrangement and Chernobyl related thyroid cancers.

Authors:  M Santoro; G A Thomas; G Vecchio; G H Williams; A Fusco; G Chiappetta; V Pozcharskaya; T I Bogdanova; E P Demidchik; E D Cherstvoy; L Voscoboinik; N D Tronko; A Carss; H Bunnell; M Tonnachera; J Parma; J E Dumont; G Keller; H Höfler; E D Williams
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

Review 6.  Thyroid Cancer in the Pediatric Population.

Authors:  Vera A Paulson; Erin R Rudzinski; Douglas S Hawkins
Journal:  Genes (Basel)       Date:  2019-09-18       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.